These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12713633)

  • 1. Oncocytic thyroid carcinoma with extensive myxoid stroma.
    Kuma S; Hirokawa M; Miyauchi A; Kakudo K
    Histopathology; 2003 May; 42(5):514-6. PubMed ID: 12713633
    [No Abstract]   [Full Text] [Related]  

  • 2. Hurthle cell carcinoma with myxoid stroma - a rare entity and a diagnosis pitfall.
    Li C; Mazhari M; Perera M; Rana DN
    Cytopathology; 2010 Apr; 21(2):120-2. PubMed ID: 20059506
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncocytic carcinoma ex pleomorphic adenoma.
    Etit D; Tan A; Bayol U; Altinel D; Cumurcu S; Cukurova I
    Head Neck Pathol; 2010 Mar; 4(1):49-52. PubMed ID: 20237989
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytology of "clear cell" variant of oncocytic/Hürthle cell carcinoma of the thyroid.
    Sturgis CD; Chang HS; Boudousquie AC
    Diagn Cytopathol; 2011 Aug; 39(8):595-7. PubMed ID: 21761577
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of metastatic lung tumor from an occult thyroid oncocytic carcinoma growing into the bronchial lumen].
    Mitani A; Saku N; Hironaka M; Ohno S; Sohara Y; Saito K; Sugiyama Y
    Nihon Kokyuki Gakkai Zasshi; 2003 Nov; 41(11):822-6. PubMed ID: 14661556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.
    Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recently identified renal cell carcinoma].
    Zhao M; Teng XD; Sun K; Cheng L
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):478-82. PubMed ID: 24246873
    [No Abstract]   [Full Text] [Related]  

  • 8. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K.
    Han F; Zhang L; Zhang S; Zhou H; Yi X
    Int J Clin Exp Pathol; 2015; 8(5):5896-901. PubMed ID: 26191315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hurthle cell neoplasm of the thyroid gland.
    Sidhu S
    ANZ J Surg; 2008 Mar; 78(3):115. PubMed ID: 18269467
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.
    Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S
    PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
    Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
    J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. My approach to oncocytic tumours of the thyroid.
    Asa SL
    J Clin Pathol; 2004 Mar; 57(3):225-32. PubMed ID: 14990587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and outcome of the oncocytic variant of papillary thyroid carcinoma.
    Gross M; Eliashar R; Ben-Yaakov A; Weinberger JM; Maly B
    Ann Otol Rhinol Laryngol; 2009 May; 118(5):374-81. PubMed ID: 19548388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Thomas J; Stinson WA
    Int J Surg Pathol; 2005 Jan; 13(1):37-41. PubMed ID: 15735853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxyphilic papillary thyroid carcinomas.
    Beckner ME; Heffess CS; Oertel JE
    Am J Clin Pathol; 1995 Mar; 103(3):280-7. PubMed ID: 7872249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hurthle cell thyroid carcinoma: report of 13 cases].
    Gerenova J; Preumont V; Rahier J; Daumerie Ch; Buysschaert M
    Acta Clin Belg; 2002; 57(3):148-53. PubMed ID: 12212356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncocytic epithelial-myoepithelial carcinoma: an evolving new variant with comparative immunohistochemistry.
    Antic T; Venkataraman G; Oshima K
    Pathology; 2008 Jun; 40(4):415-8. PubMed ID: 18446637
    [No Abstract]   [Full Text] [Related]  

  • 18. E2F-1 transcription factor is overexpressed in oxyphilic thyroid tumors.
    Volante M; Croce S; Pecchioni C; Papotti M
    Mod Pathol; 2002 Oct; 15(10):1038-43. PubMed ID: 12379749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration (FNA)-induced necrosis of tumours of the thyroid.
    Ramp U; Pfitzer P; Gabbert HE
    Cytopathology; 1995 Aug; 6(4):248-54. PubMed ID: 8520004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
    Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
    Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.